Sarah joined the Novartis Foundation in 2020 and in her role has been responsible for overseeing the impact measurement of the Better Hearts Better Cities initiatives, building CV population health approaches and developing opportunities for cross-sectoral partnerships on data and digital health in LMICs. Prior to joining Novartis, Sarah worked as a management consultant for PwC and advised major pharmaceutical companies on their strategy & operations, market access strategies and digital transformations. She worked on several assignments with global health organizations (WHO, GAVI, Global Fund) on topics grant monitoring and impact evaluation. Sarah started her career in global health and held various roles at WHO, UNAIDS and CHAI in the areas of access to medicines, health systems strengthening and monitoring & evaluation. She has extensive expensive working with health authorities in Kenya, Tanzania, Cameroon, Haiti and Thailand. Sarah holds an MSc in International Health Policy.